Literature DB >> 25726561

Cellular interactions in the pathogenesis of interstitial lung diseases.

Gianluca Bagnato1, Sergio Harari2.   

Abstract

Interstitial lung disease (ILD) encompasses a large and diverse group of pathological conditions that share similar clinical, radiological and pathological manifestations, despite potentially having quite different aetiologies and comorbidities. Idiopathic pulmonary fibrosis (IPF) represents probably the most aggressive form of ILD and systemic sclerosis is a multiorgan fibrotic disease frequently associated with ILD. Although the aetiology of these disorders remains unknown, in this review we analyse the pathogenic mechanisms by cell of interest (fibroblast, fibrocyte, myofibroblast, endothelial and alveolar epithelial cells and immune competent cells). New insights into the complex cellular contributions and interactions will be provided, comparing the role of cell subsets in the pathogenesis of IPF and systemic sclerosis.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25726561     DOI: 10.1183/09059180.00003214

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  83 in total

Review 1.  Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

Authors:  Aryeh Fischer; Jörg Distler
Journal:  Clin Rheumatol       Date:  2019-08-19       Impact factor: 2.980

2.  Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.

Authors:  Eleanor Valenzi; Melissa Bulik; Tracy Tabib; Christina Morse; John Sembrat; Humberto Trejo Bittar; Mauricio Rojas; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2019-08-12       Impact factor: 19.103

3.  Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.

Authors:  Nicola Ronan; Deirdre M Bennett; Kashif A Khan; Yvonne McCarthy; Darren Dahly; Louise Bourke; Adeline Chelliah; Alberto Cavazza; Kevin O'Regan; Fiachra Moloney; Barry J Plant; Michael T Henry
Journal:  Lung       Date:  2018-07-31       Impact factor: 2.584

4.  Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Authors:  Taku Nakashima; Tianju Liu; Biao Hu; Zhe Wu; Matthew Ullenbruch; Keitaro Omori; Lin Ding; Noboru Hattori; Sem H Phan
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

Review 5.  Bioengineering the Blood-gas Barrier.

Authors:  Katherine L Leiby; Micha Sam Brickman Raredon; Laura E Niklason
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 9.090

6.  Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis.

Authors:  A Tomaru; T Kobayashi; J A Hinneh; P Baffour Tonto; C N D'Alessandro-Gabazza; H Fujimoto; K Fujiwara; Y Takahashi; M Ohnishi; T Yasuma; K Nishihama; M Yoshino; K Takao; M Toda; T Totoki; Y Takei; K Yoshikawa; O Taguchi; E C Gabazza
Journal:  Gene Ther       Date:  2017-08-18       Impact factor: 5.250

7.  Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice.

Authors:  Elya A Shamskhou; Michael J Kratochvil; Mark E Orcholski; Nadine Nagy; Gernot Kaber; Emily Steen; Swathi Balaji; Ke Yuan; Sundeep Keswani; Ben Danielson; Max Gao; Carlos Medina; Abinaya Nathan; Ananya Chakraborty; Paul L Bollyky; Vinicio A De Jesus Perez
Journal:  Biomaterials       Date:  2019-02-22       Impact factor: 12.479

8.  Air Pollution and Interstitial Lung Diseases: Defining Epigenomic Effects.

Authors:  Gillian C Goobie; Mehdi Nouraie; Yingze Zhang; Daniel J Kass; Christopher J Ryerson; Christopher Carlsten; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

Review 9.  Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.

Authors:  Marta Bueno; Anna Papazoglou; Eleanor Valenzi; Mauricio Rojas; Robert Lafyatis; Ana L Mora
Journal:  Curr Rheumatol Rep       Date:  2020-06-19       Impact factor: 4.592

10.  Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Authors:  Barbara Ruaro; Stefano Soldano; Vanessa Smith; Sabrina Paolino; Paola Contini; Paola Montagna; Carmen Pizzorni; Andrea Casabella; Samuele Tardito; Alberto Sulli; Maurizio Cutolo
Journal:  Rheumatol Int       Date:  2019-05-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.